Manulife (Manufacturers Life Insurance)’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.41M Buy
315,102
+56,970
+22% +$797K ﹤0.01% 1221
2025
Q1
$3.51M Buy
258,132
+49,611
+24% +$674K ﹤0.01% 1296
2024
Q4
$4.25M Buy
208,521
+1,702
+0.8% +$34.7K ﹤0.01% 1272
2024
Q3
$6.02M Buy
206,819
+34,538
+20% +$1.01M 0.01% 1128
2024
Q2
$4M Buy
172,281
+23,165
+16% +$538K ﹤0.01% 1258
2024
Q1
$3.06M Buy
149,116
+47,893
+47% +$983K ﹤0.01% 1363
2023
Q4
$2.17M Sell
101,223
-12,175
-11% -$261K ﹤0.01% 1444
2023
Q3
$2.34M Sell
113,398
-5,551
-5% -$115K ﹤0.01% 1389
2023
Q2
$3.51M Buy
118,949
+3,766
+3% +$111K ﹤0.01% 1235
2023
Q1
$2.65M Buy
115,183
+3,124
+3% +$72K ﹤0.01% 1324
2022
Q4
$3.14M Buy
112,059
+1,802
+2% +$50.5K ﹤0.01% 1261
2022
Q3
$3.29M Sell
110,257
-10,030
-8% -$299K ﹤0.01% 1236
2022
Q2
$3.5M Buy
120,287
+2,202
+2% +$64.1K ﹤0.01% 1256
2022
Q1
$3.82M Buy
118,085
+71,589
+154% +$2.31M ﹤0.01% 1313
2021
Q4
$2.09K Sell
46,496
-439
-0.9% -$20 ﹤0.01% 1481
2021
Q3
$2.37M Sell
46,935
-4,398
-9% -$222K ﹤0.01% 1457
2021
Q2
$4.03M Buy
51,333
+15,287
+42% +$1.2M ﹤0.01% 1372
2021
Q1
$2.06M Sell
36,046
-2,218
-6% -$127K ﹤0.01% 1528
2020
Q4
$3.21M Buy
38,264
+1,117
+3% +$93.6K ﹤0.01% 1387
2020
Q3
$1.33M Sell
37,147
-1,051
-3% -$37.7K ﹤0.01% 1552
2020
Q2
$905K Buy
38,198
+4,727
+14% +$112K ﹤0.01% 1664
2020
Q1
$586K Buy
33,471
+3,027
+10% +$53K ﹤0.01% 1753
2019
Q4
$530K Sell
30,444
-839
-3% -$14.6K ﹤0.01% 2012
2019
Q3
$496K Sell
31,283
-44
-0.1% -$698 ﹤0.01% 2022
2019
Q2
$650K Buy
31,327
+249
+0.8% +$5.17K ﹤0.01% 1887
2019
Q1
$722K Buy
31,078
+2,977
+11% +$69.2K ﹤0.01% 1874
2018
Q4
$581K Sell
28,101
-3,042
-10% -$62.9K ﹤0.01% 1882
2018
Q3
$677K Buy
31,143
+15,499
+99% +$337K ﹤0.01% 2069
2018
Q2
$238K Buy
15,644
+1,179
+8% +$17.9K ﹤0.01% 2988
2018
Q1
$285K Buy
+14,465
New +$285K ﹤0.01% 2746